HumacyteNASDAQ: HUMA

Humacyte Inc (NASDAQ: HUMA) opened close to 25% up on Monday after the Food & Drug Administration granted its ATEV a special advanced-therapy designation.  Shares of the biotech firm are still down some 30% versus their year-to-date high.

– Third RMAT designation by FDA for ATEV – – RMAT will expedite development of ATEV in PAD – DURHAM, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, has been granted the U.S. Food and Drug Administration's (FDA's) Regenerative Medicine Advanced Therapy (RMAT) designation for patients with advanced peripheral artery disease (PAD).

Humacyte, Inc. (HUMA) reachead $5.17 at the closing of the latest trading day, reflecting a -1.34% change compared to its last close.

This week in Cheap Seats: Stocks Under $20 segment, we're taking a look at two stocks that are soaring today: Humacyte Inc (NYSE:HUMA) and American Semiconductor Corp (NASDAQ:AMSC).

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, in New York, NY on Thursday, June 6, 2024. Management will also be available for one-on-one meetings.

U.S. Senators and Congress members are known for making profitable and unconventional stock choices, leading some to suspect they have access to insider information due to their timing and success rates.

Senator Tommy Tuberville announced on April 15 that he had bought shares of Humacyte Inc. (NASDAQ: HUMA). Just four days later, HUMA's stock price jumped by 43%, leading to concerns about possible insider trading.

As the stock market remains unstable and recent gains are at risk, insider trading continues to occur. Senator Tommy Tuberville is one of the individuals taking advantage of this situation.

Tommy Tuberville, a GOP Senator representing Alabama, reported 19 fresh stock transactions on April 15th, with one trade in particular sparking significant fluctuations in the stock price.